BACKGROUND AND OBJECTIVES: The empiric use of a high plasma to packed red-blood-cell [fresh frozen plasma:red-blood-cells (FFP:RBC)] ratio in trauma resuscitation for patients with massive bleeding has become well accepted without clear or objective indications. Increased plasma transfusion is associated with worse outcome in some patient populations. While previous studies analyse only patients who received a massive transfusion, this study analyses those that are at risk to receive a massive transfusion, based on the trauma-associated severe haemorrhage (TASH) score, to objectively determine which patients after severe trauma would benefit or have increased complications by the use of a high FFP:RBC ratio. METHODS: Multicentre retrospective study from the Trauma Registry of the German Trauma Society. Multivariate logistic regression and statistical risk adjustments utilized in analyses. RESULTS: A high ratio of FFP:RBC in the ≥15 TASH group was independently associated with survival, with an odds ratio of 2·5 (1·6-4·0), while the <15 TASH group was associated with increased multi-organ failure, 47% vs. 38%, (P<0·005). CONCLUSIONS: A predictive model of massive transfusion upon admission might be able to rapidly identify which severe trauma patients would benefit or have increased complications from the immediate application of a high ratio of FFP:RBCs. This study helps to identify the appropriate population for a prospective, interventional trial.
BACKGROUND AND OBJECTIVES: The empiric use of a high plasma to packed red-blood-cell [fresh frozen plasma:red-blood-cells (FFP:RBC)] ratio in trauma resuscitation for patients with massive bleeding has become well accepted without clear or objective indications. Increased plasma transfusion is associated with worse outcome in some patient populations. While previous studies analyse only patients who received a massive transfusion, this study analyses those that are at risk to receive a massive transfusion, based on the trauma-associated severe haemorrhage (TASH) score, to objectively determine which patients after severe trauma would benefit or have increased complications by the use of a high FFP:RBC ratio. METHODS: Multicentre retrospective study from the Trauma Registry of the German Trauma Society. Multivariate logistic regression and statistical risk adjustments utilized in analyses. RESULTS: A high ratio of FFP:RBC in the ≥15 TASH group was independently associated with survival, with an odds ratio of 2·5 (1·6-4·0), while the <15 TASH group was associated with increased multi-organ failure, 47% vs. 38%, (P<0·005). CONCLUSIONS: A predictive model of massive transfusion upon admission might be able to rapidly identify which severe traumapatients would benefit or have increased complications from the immediate application of a high ratio of FFP:RBCs. This study helps to identify the appropriate population for a prospective, interventional trial.
Authors: Stefan Huber-Wagner; Rolf Lefering; Lars-Mikael Qvick; Markus Körner; Michael V Kay; Klaus-Jürgen Pfeifer; Maximilian Reiser; Wolf Mutschler; Karl-Georg Kanz Journal: Lancet Date: 2009-03-25 Impact factor: 79.321
Authors: John R Hess; Karim Brohi; Richard P Dutton; Carl J Hauser; John B Holcomb; Yoram Kluger; Kevin Mackway-Jones; Michael J Parr; Sandro B Rizoli; Tetsuo Yukioka; David B Hoyt; Bertil Bouillon Journal: J Trauma Date: 2008-10
Authors: Christopher W Snyder; Jordan A Weinberg; Gerald McGwin; Sherry M Melton; Richard L George; Donald A Reiff; James M Cross; Jennifer Hubbard-Brown; Loring W Rue; Jeffrey D Kerby Journal: J Trauma Date: 2009-02
Authors: E Bui; K Inaba; A Ebadat; E Karamanos; S Byerly; O Okoye; I Shulman; P Rhee; D Demetriades Journal: Eur J Trauma Emerg Surg Date: 2015-09-11 Impact factor: 3.693
Authors: Heather F Pidcoke; Claire L Isbell; Maryanne C Herzig; Chriselda G Fedyk; Beverly S Schaffer; Kevin K Chung; Christopher E White; Steven E Wolf; Charles E Wade; Andrew P Cap Journal: J Trauma Acute Care Surg Date: 2015-06 Impact factor: 3.313
Authors: Henrik Bjursten; Alain Dardashti; Per Ederoth; Björn Brondén; Lars Algotsson Journal: Intensive Care Med Date: 2012-10-10 Impact factor: 17.440
Authors: Ruth S Hwu; Philip C Spinella; Martin S Keller; David Baker; Michael Wallendorf; Julie C Leonard Journal: Transfusion Date: 2016-08-29 Impact factor: 3.157
Authors: Elaheh Rahbar; Erin E Fox; Deborah J del Junco; John A Harvin; John B Holcomb; Charles E Wade; Martin A Schreiber; Mohammad H Rahbar; Eileen M Bulger; Herb A Phelan; Karen J Brasel; Louis H Alarcon; John G Myers; Mitchell J Cohen; Peter Muskat; Bryan A Cotton Journal: J Trauma Acute Care Surg Date: 2013-07 Impact factor: 3.313
Authors: Mohammad H Rahbar; Deborah J del Junco; Hanwen Huang; Jing Ning; Erin E Fox; Xuan Zhang; Martin A Schreiber; Karen J Brasel; Eileen M Bulger; Charles E Wade; Bryan A Cotton; Herb A Phelan; Mitchell J Cohen; John G Myers; Louis H Alarcon; Peter Muskat; John B Holcomb Journal: J Trauma Acute Care Surg Date: 2013-07 Impact factor: 3.313
Authors: Mitchell Jay Cohen; Matt Kutcher; Britt Redick; Mary Nelson; Mariah Call; M Margaret Knudson; Martin A Schreiber; Eileen M Bulger; Peter Muskat; Louis H Alarcon; John G Myers; Mohammad H Rahbar; Karen J Brasel; Herb A Phelan; Deborah J del Junco; Erin E Fox; Charles E Wade; John B Holcomb; Bryan A Cotton; Nena Matijevic Journal: J Trauma Acute Care Surg Date: 2013-07 Impact factor: 3.313
Authors: Amber W Trickey; Erin E Fox; Deborah J del Junco; Jing Ning; John B Holcomb; Karen J Brasel; Mitchell J Cohen; Martin A Schreiber; Eileen M Bulger; Herb A Phelan; Louis H Alarcon; John G Myers; Peter Muskat; Bryan A Cotton; Charles E Wade; Mohammad H Rahbar Journal: J Trauma Acute Care Surg Date: 2013-07 Impact factor: 3.313